Welcome to Cora · $15 off your first month · use CORA15 at checkout→
24/7 Messaging SupportLegitScript-Certified100% OnlineUS-Licensed PharmaciesFree ShippingProvider Review in 24 HoursHSA/FSA Accepted24/7 Messaging SupportLegitScript-Certified100% OnlineUS-Licensed PharmaciesFree ShippingProvider Review in 24 HoursHSA/FSA Accepted
Pricing breakdown · October 2026

What does tirzepatide actually cost in 2026?

Quick answer

As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. As of October 15, 2026, Lilly’s January 1, 2026 wholesale acquisition costs (WAC) are $499–$1,086.37 per fill for Zepbound® and $1,112.16 per four-pen fill for Mounjaro®. These are list prices, not pharmacy cash-price quotes. Mounjaro® is approved for type 2 diabetes, not weight management. As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

At a glance

Source Monthly cost What you get
List price (Lilly WAC, Jan 2026): Zepbound® / Mounjaro®; verified October 15, 2026 $499–$1,086.37 / $1,112.16 per fill FDA-approved products; list prices are not pharmacy quotes. Mounjaro® is not approved for weight management.
Brand-name Zepbound® via LillyDirect®; verified October 15, 2026 $299 (2.5 mg) – $449/month with Journey refills within 45 days; otherwise $499 (7.5 mg) / $699 (10–15 mg) Vials or KwikPen: 2.5 mg $299 (starting dose, not maintenance); 5 mg $399; 7.5–15 mg $449 with Journey refill within 45 days, otherwise $499 at 7.5 mg/$699 at 10–15 mg. 28-day month; needles/syringes extra.
Compounded tirzepatide prescribed through Cora Health (Premium Plan, annual) $135/month ($1,620 billed upfront every 12 months) October 2026: includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Plans renew automatically until you cancel. Prices may change. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.
Compounded tirzepatide prescribed through Cora Health (Premium Plan, monthly) $225/month ($225 billed monthly) October 2026: includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Plans renew automatically until you cancel. Prices may change. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

Cancellation policy. Manufacturer self-pay eligibility and terms apply; prices verified October 15, 2026. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. Zepbound®, Mounjaro®, LillyDirect® and KwikPen® are registered trademarks of Eli Lilly and Company.

Brand-name tirzepatide cost: Mounjaro® and Zepbound®

As of October 15, 2026, Lilly’s January 1, 2026 wholesale acquisition costs (WAC) are $499–$1,086.37 per fill for Zepbound® and $1,112.16 per four-pen fill for Mounjaro®. These are list prices, not pharmacy cash-price quotes. Mounjaro® is approved for type 2 diabetes, not weight management.

As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately.

LillyDirect dose prices and conditions · Lilly Zepbound® list prices · Lilly Mounjaro® list price. Brand names are registered trademarks of their respective owners.

Compounded tirzepatide cost

As of October 2026, compounded tirzepatide is prepared under a patient-specific prescription. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. The FDA does not review compounded medications for safety, effectiveness or quality before marketing.

As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

Cora Premium Plan tier Monthly Billed Notes
Annual (12 months) $135/mo $1,620 every 12 months Billed upfront every 12 months; renews automatically
Semi-Annual (6 months) $175/mo $1,050 every 6 months Billed upfront every 6 months; renews automatically
Quarterly (3 months) $199/mo $597 every 3 months Billed upfront every 3 months; renews automatically
Monthly $225/mo $225 billed monthly Billed monthly; renews automatically until you cancel

Licensed providers at Wasef Health, PC make prescribing decisions. Prescriptions are fulfilled by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Cora Health does not prescribe or compound medication. Prices as of October 2026; plans renew automatically until you cancel; prices may change. Cancellation policy.

As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

Does the price of compounded tirzepatide change with the dose?

On Cora Health's standard plans, no. The standard plan charges one price per billing term for compounded tirzepatide, and that price is the same at every dose your provider prescribes on that plan — including when your dose increases partway through a prepaid plan. Cora's microdose plans are separate, with their own intake, one fixed weekly dose and their own prices; a higher dose is not part of a microdose plan. On the standard plan, compounded tirzepatide is $135/month on the annual plan, $175/month semi-annual, $199/month quarterly, or $225/month month to month; the table above shows what each term bills. Each price includes the provider consultation, the medication, expedited shipping and ongoing monitoring. Your dose is set by a licensed provider at Wasef Health, PC — Cora Health does not prescribe. Medication is compounded by US-licensed 503A pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Plans renew automatically until you cancel, and on prepaid plans the per-month rate applies to the completed term — see our refund and cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.

Prices verified against Cora's billing system on November 2, 2026.

Compounded tirzepatide prices across telehealth providers (Cora Health dataset, July 2026 edition)

Cora Health pricing dataset, July 2026 edition: effective monthly competitor costs include any recorded membership fee and may have changed since collection. Selected providers from the dataset are shown; the public dataset lists every row. “All-inclusive?” here means no separate membership fee in the dataset; verify consultation, laboratory, shipping and other charges directly. “—” means no matching dataset row for that term, not that a provider cannot offer it. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Cora Health’s own terms below are current as of October 2026; cancellation policy.

Provider Annual Semi-Annual Quarterly Monthly All-inclusive? Pharmacy named?
Cora Health Premium Plan (standard plan; microdose plans priced separately) — October 2026 (this site) $135/mo ($1,620 billed upfront every 12 months); renews automatically until you cancel. Prices may change. Includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. $175/mo ($1,050 billed upfront every 6 months); renews automatically until you cancel. Prices may change. Includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. $199/mo ($597 billed upfront every 3 months); renews automatically until you cancel. Prices may change. Includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. $225/mo ($225 billed monthly); renews automatically until you cancel. Prices may change. Includes consultation, compounded medication, pharmacy fulfillment, expedited shipping and monitoring; licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Yes US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx
Eden (TryEden) — Cora Health pricing dataset, July 2026 edition — — — $298/mo No (membership) No (dataset)
Belle Health — Cora Health pricing dataset, July 2026 edition — $199/mo $175/mo; starter-dose bundle only $249/mo Yes Yes (dataset)
Lemonaid Health — Cora Health pricing dataset, July 2026 edition — $278/mo $298/mo $348/mo No (membership) No (dataset)
Ivim Health — Cora Health pricing dataset, July 2026 edition — — — $207.99/mo No (membership) No (dataset)
Joi + Blokes — Cora Health pricing dataset, July 2026 edition — — $299/mo — Yes No (dataset)

Competitor figures: Cora Health pricing dataset, July 2026 edition; prices may have changed since collection. Starter and commitment conditions are shown in their cells. Public dataset and sources (CC-BY-4.0). Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

What is included in the price, and what to compare

As of October 2026, compare the total checkout amount, required membership, consultation, laboratory services, shipping, follow-ups, dose conditions and prepaid term. Ask for a written breakdown before purchasing. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

Cora Health’s standard plans include the licensed-provider consultation, compounded tirzepatide, US-licensed 503A pharmacy fulfillment, expedited shipping and ongoing monitoring. There is no separate membership, follow-up or dose-escalation fee on standard plans. Plans renew automatically until you cancel. Prices may change. A licensed provider decides eligibility. Cancellation policy. Compounded medications are not FDA-approved.

Tirzepatide and insurance coverage

As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer.

As of October 2026, Cora Health does not bill insurance. Discuss reimbursement questions directly with your insurer. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

Brand-name and compounded tirzepatide: payment options and prices (as of October 2026)

As of October 2026, these options differ in product, FDA-approval status, eligibility and payment conditions; compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Zepbound®. Discuss which medication is appropriate for you with a licensed provider.

  • As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer.
  • As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately.
  • As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.
  • Reference only (manufacturer list prices; what you pay depends on your insurance and pharmacy): As of October 15, 2026, Lilly’s January 1, 2026 wholesale acquisition costs (WAC) are $499–$1,086.37 per fill for Zepbound® and $1,112.16 per four-pen fill for Mounjaro®. These are list prices, not pharmacy cash-price quotes. Mounjaro® is approved for type 2 diabetes, not weight management.

Frequently asked questions about tirzepatide cost

How much does tirzepatide cost without insurance in 2026?

As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. As of October 15, 2026, Lilly’s January 1, 2026 wholesale acquisition costs (WAC) are $499–$1,086.37 per fill for Zepbound® and $1,112.16 per four-pen fill for Mounjaro®. These are list prices, not pharmacy cash-price quotes. Mounjaro® is approved for type 2 diabetes, not weight management. As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

What lower-cost tirzepatide options exist in 2026, brand-name or compounded?

As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. Discuss which medication is appropriate for you with a licensed provider.

How do compounded and brand-name tirzepatide prices differ?

As of October 2026, brand-name and compounded products have different regulatory and production structures. Patient-specific compounded tirzepatide is prepared by a US-licensed 503A compounding pharmacy under a licensed provider’s prescription. FDA-approved brands have clinical development, commercial manufacturing and post-market monitoring costs. A price difference does not establish equivalent safety, quality or effectiveness. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. The FDA does not review compounded medications for safety, effectiveness or quality before marketing.

Is tirzepatide covered by insurance?

As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer. Mounjaro® is approved for type 2 diabetes, not weight management. Cora Health does not bill insurance; confirm any reimbursement questions with your plan. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

How much does tirzepatide cost per month in 2026?

The applicable price depends on dose, insurance and billing term; no single price applies to everyone. As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

What price will I pay for tirzepatide in 2026?

Compare the price available for your prescribed dose and coverage, including the prepaid term and any membership fees. As of October 15, 2026, eligible commercially insured patients whose plan covers the Zepbound® single-dose pen may pay as little as $25 for a 1-, 2- or 3-month prescription fill with the Zepbound® savings card; savings are capped at $100, $200 or $300 per fill and $1,300 per calendar year, and the card ends December 31, 2026. Government beneficiaries are excluded; eligibility and program terms apply. Confirm coverage, deductible and prior authorization with your insurer. As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms.

Can I get tirzepatide online?

As of October 2026, licensed telehealth providers may prescribe FDA-approved Zepbound® or Mounjaro® when clinically appropriate. Mounjaro® is not approved for weight management. Through Cora Health, independent licensed providers at Wasef Health, PC decide eligibility for patient-specific compounded tirzepatide prescriptions, fulfilled by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy (PCAB-accredited) and VialsRx. Cora Health does not prescribe or compound medication. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®.

How much does compounded tirzepatide cost per month on a yearly plan, and what does Zepbound® cost over a year?

As of October 2026, on the Cora Health Premium Plan, compounded tirzepatide prescribed through Cora Health is $135/month ($1,620 billed upfront every 12 months), $175/month ($1,050 billed upfront every 6 months), $199/month ($597 billed upfront every 3 months), or $225/month ($225 billed monthly). Plans renew automatically until you cancel; cancellation policy. Prices may change. Includes licensed-provider consultation, compounded medication, pharmacy fulfillment, expedited shipping and ongoing monitoring. A licensed provider decides eligibility. Premium Plan pricing does not increase with the prescribed dose. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved Zepbound®/Mounjaro®. Other telehealth providers also offer compounded tirzepatide; some providers in the Cora Health pricing dataset (July 2026 edition), compared on this page, list lower prices than Cora Health on some billing terms. As of October 15, 2026, LillyDirect® Zepbound® single-dose vials (four per month) and KwikPen® cost $299 per 28-day month at 2.5 mg (starting dose, not maintenance), $399 at 5 mg, and $449 at 7.5, 10, 12.5 or 15 mg with the Zepbound Self Pay Journey Program when refilled within 45 days. Otherwise, regular prices are $499 at 7.5 mg and $699 at 10–15 mg. Eligibility and program terms apply; needles/syringes are purchased separately. Lilly defines a month as 28 days/four weekly doses, so a 52-week year requires 13 fills: at verified October 15, 2026 prices, 13 × $399 = $5,187 for Zepbound® 5 mg, or 13 × $449 = $5,837 at 7.5–15 mg with Journey refills within 45 days; otherwise $499 at 7.5 mg/$699 at 10–15 mg per fill. Needles/syringes cost extra. These illustrations assume unchanged pricing; they are not dosing schedules or annual-plan offers.

See if compounded tirzepatide is right for you

Take Cora Health's online assessment. A licensed provider reviews your health profile and — when clinically appropriate — writes a patient-specific prescription. Compounded tirzepatide is not FDA-approved. Individual results vary.

See Cora Health Premium Plan

Cora Health does not prescribe medication. Pharmacy partners · Safety · FAQs